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Background: SCARB2 is the cellular receptor for EV71.
Results:SevenhighlyvariableaminoacidsonSCARB2andaregioninproximitytoresidueGln-172ofVP1arecriticalforEV71
infection.
Conclusion: EV71 might adopt the canyon receptor engagement mode for viral entry.
Significance: Elucidation of receptor and viral determinants revealed a possible target for anti-EV71 interventions.
Enterovirus 71 (EV71) is one of the major pathogens that
cause hand, foot, and mouth disease outbreaks in young chil-
dren in the Asia-Pacific region in recent years. Human scav-
enger receptor class B 2 (SCARB2) is the main cellular receptor
forEV71ontargetcells.TherequirementsoftheEV71-SCARB2
interactionhavenotbeenfullycharacterized,andithasnotbeen
determined whether SCARB2 serves as an uncoating receptor
for EV71. Here we compared the efficiency of the receptor from
different species including human, horseshoe bat, mouse, and
hamster and demonstrated that the residues between 144 and
151 are critical for SCARB2 binding to viral capsid protein VP1
ofEV71andsevenresiduesfromthehumanreceptorcouldcon-
vert murine SCARB2, an otherwise inefficient receptor, to an
efficient receptor for EV71 viral infection. We also identified
thatEV71bindstoSCARB2viaacanyonofVP1aroundresidue
Gln-172. Soluble SCARB2 could convert the EV71 virions from
160Sto135Sparticles,indicatingthatSCARB2isanuncoating
receptor of the virus. The uncoating efficiency of SCARB2 sig-
nificantly increased in an acidic environment (pH 5.6). These
studieselucidatedtheviralcapsidandreceptordeterminantsof
enterovirus 71 infection and revealed a possible target for anti-
viral interventions.
Enterovirus 71 (EV71)
3 belongs to human enterovirus spe-
cies A of the genus Enterovirus within the Picornaviridae fam-
ily. It is genetically close to another human enterovirus species
A virus, coxsackievirus A16 (CA16) (1). Both EV71 and CA16
are common causes of hand-foot-mouth disease (HFMD) that
mostlyaffectyoungchildren.HFMDisoftenmild,self-limiting,
and characterized by symptoms of fever, sore throat, diarrhea,
andpapulovesicularrashonthehands,feet,andoropharyngeal
mucosa. However, unlike CA16, EV71 infection can also cause
severe neurological complications such as acute encephalitis,
poliomyelitis-like paralysis, and aseptic meningitis with or
without pulmonary edema disease. The EV71-associated neu-
rologicalcomplicationscansometimesbefatal,andneurogenic
pulmonaryedemaisthoughttobethemainpathogenicprocess
in fatal cases (2–5). EV71 infections manifested with severe
neurological diseases with high mortality rates were first
reported in Bulgaria in 1975 and Hungary in 1978 (6, 7). Two
decades later, large and severe HFMD epidemics reemerged in
Malaysia in 1997 and Taiwan in 1998 and 2000 (8, 9). Since
then, there have been more frequent large scale EV71-associ-
ated epidemics throughout the Asia-Pacific region, and fatal
instances of neurotropic infections have become increasingly
common,particularlyinSoutheastandEastAsia.BetweenJan-
uary 2009 and May 2011, the EV71 epidemics in China have
resultedinmorethantwomillionHFMDcasesandabout1000
deaths.
4 As poliovirus, which causes poliomyelitis, is nearly
eradicated, EV71 has emerged as an important human entero-
virus and raised considerable public health concerns (11, 12).
However,effectiveantiviralagentsorvaccinesagainstEV71are
currently unavailable.
EV71 is a nonenveloped virus comprising a positive single-
strandedRNAgenome(7.4kbinlength)thatispackedwithin
an outer protein capsid usually composed of four proteins
(VP1–VP4) (1). Based on homologous structural modeling of
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Supplemental Material can be found at:the EV71 capsid proteins, the overall architecture of the virion
is believed to be similar to other enteroviruses (e.g. poliovirus)
in the picornavirus family (13). The capsid of the virus has an
icosahedralsymmetryandis30nmindiameter.Itconsistsof
60copiesofpentamericsubunitsthatareformedbyeachofthe
four capsid proteins, VP1, VP2, VP3, and VP4 (14, 15). VP1–
VP3ofpicornavirusesareexposedonthevirionsurfaceandare
responsible for host-receptor binding, whereas VP4 is located
insidetheparticle.VP1isthemostexternal,surface-accessible,
and immunodominant protein among the picornavirus capsid
proteins (16).
It has been shown that EV71 enters host cells via a receptor-
mediated endocytosis pathway that is pH- and clathrin-depen-
dent (17). Two human functional receptors for EV71 have
recently been identified: human P-selectin glycoprotein
ligand-1(PSGL-1;CD162)andhumanscavengerreceptorclass
B2(SCARB2;alsoknownaslysosomalmembraneproteinIIor
CD36b-like-2) (18, 19). The PSGL-1 is expressed mainly on
leukocytes, and it is likely that PSGL-1 primarily serves as a
receptor for EV71 infection of leukocytes (19). It has also been
shown that tyrosine sulfation, but not O-glycosylation, in the
N-terminalregionofPSGL-1mayfacilitatevirusentryandrep-
lication of EV71 in leukocytes (20). SCARB2 is a type III multi-
pletransmembraneglycoproteinwithbothNandCterminion
the cytosol side (21) located primarily in the membranes of
lysosomesandendosomesandhasbeendemonstratedasaspe-
cific receptor for targeting -glucocerebrosidase to lysosomes
(22).SCARB2iswidelyexpressedondifferentcelltypesinclud-
ingneurons;itmaybedirectlyinvolvedinEV71infectionofthe
brain. Moreover, unlike PSGL-1, SCARB2 can be utilized by
mostEV71strainsasanentryreceptor,indicatingthatSCARB2
may play a critical role in the early steps of EV71 infection (18,
19).Theentireexon4ofSCARB2hasbeenshownrecentlytobe
responsible for the interaction with VP1 protein of EV71 (23).
However, the detailed molecular interaction between VP1 and
SCARB2 has not been determined. It is still unknown whether
theSCARB2andVP1interactioncontributestoEV71viralpar-
ticle uncoating during the entry step of EV71 infection or
whether SCARB2 binding mediates capsid alteration during
uncoating.
In this study, using a single round pseudotype EV71 virus
infection system, we investigated the ability of several SCARB2
molecules from different species including human, mouse,
horseshoe bat, and hamster to serve as a receptor for EV71
infection. By comparing SCARB2s from human and horseshoe
bat with that of hamster and mouse SCARB2, we identified
criticalresiduesrequiredforhumanSCARB2(hSCARB2)bind-
ing to VP1; this region comprises residues 144–151 in a highly
variableregionamongspecies.Wedemonstratedthatchanging
seven residues of mouse SCARB2 (mSCARB2) to correspond-
ing residues of hSCARB2 could convert the mSCARB2 to an
efficient receptor for EV71. We further identified that the
determinant on VP1 for receptor binding, which comprises
Gln-172 and surrounding residues, forms a canyon around the
plateau on the virion surface. Finally, we showed that SCARB2,
but not PSGL-1, is an uncoating receptor for EV71, and the
uncoating efficiency of SCARB2 is significantly increased in an
acidic environment (pH 5.6).
MATERIALS AND METHODS
CellLines,Antibodies,Plasmids,andVirus
Human embryonic kidney (HEK)-293T cells, human rhab-
domyosarcoma (RD) cells, and baby hamster kidney (BHK21)
cellsweremaintainedinDulbecco’smodifiedessentialmedium
(DMEM) containing 10% fetal bovine serum and 1% penicillin/
streptomycin at 37 °C in 5% CO2. Rabbit anti-actin IgG and
horseradish peroxidase (HRP)-conjugated anti-mouse and
anti-rabbit IgG antibodies were purchased from Sigma-Al-
drich. SCARB2 cDNAs of human, mouse, horseshoe bat, and
hamster were cloned from RD cells, L929 cells, primary fibro-
blasts of horseshoe bat, and BHK21 cells, respectively. These
cDNA clones were subsequently cloned into pCAGGS vector
fused with a nine-residue C-terminal tag (C9; TETSQVAPA)
that is recognized by the mouse monoclonal antibody 1D4
(National Cell Culture Center). The virus enterovirus 71 (Fuy-
ang (FY) strain; GenBank
TM accession number EU703812;
genotypic subgroup C4) was isolated from a patient in Fuyang
City during the HFMD epidemic of 2007 in China. Virus was
propagated and titrated in RD cells.
GenerationofSCARB2KnockdownRDCells(RD/SCARB2kd)
ShorthairpinRNA(shRNA)sequences5-CCGGGACCAG-
AGTATCGAGAAGAAACTCGAGTTTCTTCTCGATACT-
CTGGTCTTTTTG-3 and 5-AATTCAAAAAGACCAGAG-
TATCGAGAAGAAACTCGAGTTTCTTCTCGATACTCT-
GGTC-3 targeting the coding sequence of human SCARB2
mRNAwereclonedintopLKO.1-purovector(Sigma)drivenby
an hU6 promoter with AgeI and EcoRI sites. For production of
the lentiviral particles, 293T cells were co-transfected with
pLKO.1-shSCARB2,psPAX2,andpMD2.G(Sigma)ataratioof
4:3:1. 48 h after transfection, the cell culture supernatant was
harvested and filtered using a 0.45-m filter membrane. RD
cells were transduced with lentiviruses carrying the transgene
pLKO.1-shSCARB2.After4daysofincubation,transducedRD
cells were screened with 2.0 g/ml puromycin (Sigma) to
obtain shSCARB2-incorporated RD (RD/SCARB2 kd) cells.
SCARB2 mRNA levels of RD cells and RD/SCARB2 kd cells
were determined by real time RT-PCR using the following
primers: hSCARB2-qF (5-CCAATACGTCAGACAATGCC)
and hSCARB2-qR (5-ACCATTCTTGCAGATGCTGA-3).
MolecularCloningofEpidemicEV71(FY)Strain
For cloning the full length of the FY RNA genome, 5  10
6
RD cells were infected with EV71(FY) with a multiplicity of
infectionof0.1,andtotalRNAwasisolatedwithTRIzolreagent
when 80–90% cells rounded up. The genome of EV71(FY) was
cloned using a PCR-based method. Briefly, three fragments
ranging from nucleotides 1 to 2859, 2859 to 5391, and 5391 to
7405 of EV71 were amplified from FY cDNA and cloned into
pMD18T vector (Takara). After sequence verification, the
threefragmentswereligatedinvitro.TheDNAsequenceofT7
promoter was added to the 5-end of the viral genome cDNA.
ProductionofReplication-competentEV71(FY)-EGFPVirus
A replication-competent EV71 with an EGFP reporter gene
(EV71(FY)-EGFP virus; Fig. 1) was generated on the basis of
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 pSVA-EV71-EGFP (18), which is an infectious clone of EV71
strain SK-EV006 (AB469182) kindly provided by Dr. Satoshi
Koike. The coding sequence of EGFP was inserted between the
5-untranslatedregion(UTR)andVP4withanEV712Aprote-
ase recognition site (-AITTL-) in between EGFP and VP4. The
structural genes of SK-EV006 in pSVA-EV71-EGFP were
replaced with EV71(FY) strain (GenBank accession number
EU703812). EV71(FY)-EGFP RNA was prepared by in vitro
transcription with a SmaI-linearized plasmid harboring
EV71(FY)-EGFP as a template using a RiboMAX large scale
RNA production kit (Promega). RD cells were transfected with
EV71(FY)-EGFP RNA by Lipofectamine 2000 (Invitrogen).
EV71(FY)-EGFP viruses were collected by two rounds of
freeze-thaw cycles when the GFP-positive cells reached
80–90% and then filtered through a 0.45-m filter, aliquoted,
and frozen at 80 °C until use.
EV71SingleRoundInfectionSystem
EV71 Subgenomic Replicon—The EV71 replicon was con-
structed by replacing the capsid coding region with a firefly
luciferase reporter gene and a T7 promoter at the 5-end for
transcription in vitro. The EV71 replicon was linearized, and 1
g of purified DNA was then used as template for EV71 repli-
con RNA synthesis with a RiboMAX large scale RNA produc-
tionkit(Promega).TranscribedRNAwaspurifiedbyisopropa-
nol precipitation and used for transfection or frozen at 80 °C
until use.
EV71 Capsid and Its Mutant Expressers—The EV71 capsid
expresser was constructed to express the structural capsid
genes in trans. EGFP gene was inserted upstream of the
EV71(FY) capsid gene and was separated by a 2A self-cleavage
site. The EGFP is used to ensure transfection efficiency of the
structuralgenes.Capsidvariantswithmutationswereprepared
by site-directed mutagenesis of VP1 and verified by DNA
sequencing.
PreparationofEV71PseudotypeVirusEV71(FY)-Luc—FYor
FYmutantpseudotypewasproducedbysequentialtransfection
ofFYorFYmutantcapsidplasmidandEV71repliconRNAinto
HEK-293T cells. Briefly, pcDNA6-FY-capsid or mutant capsid
plasmid was transfected into HEK-293T cells at 60–80% con-
fluence; 24 h post-capsid transfection, replicon RNA was then
transfected using Lipofectamine 2000 (Invitrogen). FY pseu-
dotype was harvested 24 h post-RNA transfection with two
rounds of freeze-thaw cycle.
EV71 Single Round Virus Infection—50 l of EV71(FY)-Luc
or mutant pseudotype was mixed with 50 l of fresh complete
medium supplemented with 2% FBS and applied in quadrupli-
cate to cells on a 96-well plate. Firefly luciferase activity was
measured following the Luciferase Assay System manual (Pro-
mega) at 24 h postinfection. In the case of pH dependence
experiments, cells were pretreated with bafilomycin A1 or
NH4Cl at 37 °C for 1 h. The cells were infected with EV71(FY)-
Luc at 37 °C for 1 h and then changed to fresh culture medium
after washing with PBS once.
QuantificationofVirionsbyMeasuringViralGenomeRNA
EV71(FY)-Lucpseudotypeswereproducedon293Tcellsand
frozen at 80 °C. For viral RNA quantification, 10 l of each
pseudotype was used for RNA extraction by TRIzol reagent
(Invitrogen). cDNA was synthesized with reverse transcriptase
fromMoloneymurineleukemiavirus(RNaseH
,Takara),and
virions were quantified by real time PCR (SYBR Premix Ex
TaqII (Perfect Real Time), Takara) using the primers fLuc-F
(5-caaatacgatttatctaatttacacga-3) and fLuc-R (5-ccggtatcca-
gatccacaac-3) located in the luciferase gene.
EV71(FY)-LucBindingAssayonRDCells
80 l of EV71(FY)-Luc or mutant pseudotypes (10
8 copies
of viral genome) was added to RD cells on a 48-well plate in
duplicate and incubated at 4 °C for 1.5–2 h, and unbound viri-
ons were washed away with ice-cold PBS. Bound virions were
quantifiedbyrealtimeRT-qPCRusingglyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) as a reference.
NeutralizationAssaywithSingleRoundEV71(FY)-Luc
Pseudotype
EV71(FY)-Luc pseudotype virus was incubated with anti-
EV71serumsamplefor1honiceandthenaddedtoRDcellsin
a 96-well plate in a total volume of 100 l. Luciferase activity
was measured 24 h postinfection.
SCARB2BindingSiteMapping
ChimericSCARB2mutantswereconstructedusingstandard
PCR-based methods, and all were cloned into pCAGGS-C9
vector. RD/SCARB2 kd or BHK21 cells seeded on a 24-well
plate were transfected with SCARB2 or mutants by Lipo-
fectamine 2000. At 20 h post-transfection, cells were infected
with EV71(FY)-EGFP or EV71(FY)-Luc. GFP fluorescence
images were taken at the times indicated after EV71(FY)-EGFP
infection; firefly luciferase activities were measured 24 h
postinfection.
SurfaceExpressionLevelofChimericSCARB2Mutants
CellsoverexpressingSCARB2ormutantsweresurface-bioti-
nylated with sulfo-NHS-LC-biotin (sulfosuccinimidyl 6-(bioti-
namido)hexanoate; Pierce) following the manufacturer’s
instruction manual. Then cells were lysed in 500 lo f1 %
CHAPS in PBS (Sigma) with 1 mixture protease inhibitor
(Roche Applied Science). Equal amounts of total proteins were
usedforthepulldownassay.1gof1D4(C9tag-specificmono-
clonal antibody) together with 10 l of mixed protein A and G
Dynalbeads(Invitrogen)wereaddedtothesupernatantstopull
down the C9-tagged proteins. After washing three times with
0.3% CHAPS in PBS, bound proteins were eluted by boiling in
1 loading buffer for 5 min and subsequently examined with
HRP-streptavidin (Sigma) using a Western blot assay.
ComparativeModelofVP1Structure
VP1 protein of EV71(FY) shares 36% sequence identity with
polio VP1 for which the crystal structure is available (Protein
Data Bank code 3EPC). We therefore used the polio VP1 to
model the EV71 VP1 structure with the homology modeling
program MODELER (24). The model with the best discrete
optimizedproteinenergyscore(25)usingthedefaultsettingsin
MODELER was chosen and subsequently validated using
PROCHECK. The three-dimensional architecture of EV71
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 virus capsid was constructed by replacing the VP1 domain of
poliovirus with the modeled VP1 domain of EV71 on the
cryo-EM structure of poliovirus (Protein Data Bank code
2PLV). The visualization of the virus capsid was built using the
multiscale models in Chimera (26). Representative figures of
structural models were also generated with Chimera (27).
PurificationofWildTypeEV71VirusesUsing
Ultracentrifugation
RD cells of five 15-cm dishes were infected with EV71(FY)
virus stock at a multiplicity of infection of 0.1 and cultured in
DMEM with 2% FBS. When 80–90% of cells showed a cyto-
pathic effect, the supernatant was collected and concentrated
by filtration through a 100-kDa-cutoff centrifugal filter (Milli-
pore). The concentrated virus was loaded on top of a CsCl gra-
dient (1.2–1.6 g/ml; discontinuous) followed by ultracentrifu-
gation at 52,000 rpm for1h4 5m i na t4° Ci naBeckman
SW55Ti rotor. After dialysis with PBS, the purified EV71 was
stored at 80 °C until use.
PulldownAssayofEV71withSolubleSCARB2-mFcs
SCARB2 extracellular regions of human, mouse, and chime-
ras were fused with the Fc region of mouse IgG2a to make
soluble receptors. Proteins were expressed in HEK-293T cells
and purified with protein A-Sepharose beads. 1 g of purified
soluble SCARB2-mFc was incubated with 1 l of purified
EV71(FY) wild type virus or EV71(FY)-Luc pseudovirus with
VP1 mutant (5  10
8 genome copies) in a total volume of 50
linPBSat4 °Cfor3h,andthen10lofproteinADynalbeads
(Invitrogen)wasaddedfollowedbyfurtherincubationfor1hat
4 °C.Thebeadswerethenincubatedwith300lofTRIzollysis
buffer to release bound virions after three washes with PBS
(containing 0.001% Triton X-100). The bound virions were
quantified by real time RT-PCR.
FlotationAssayofSucroseDensityGradientCentrifugation
20 l of purified virus (5  10
9 genome copies) was incu-
bated with 5 g of purified hSCARB2-mFc or hPSGL1-mFc in
PBS containing 0.5% BSA in a total volume of 100 la t4° C
overnight.ForlowpHtreatment,HClwasaddedtothemixture
tobringthepHto5.6.Themixturewasthenincubatedat37 °C
for 100 min, subsequently applied to a 15–30% discontinuous
sucrosegradient,andultracentrifugedat40,000rpmfor70min
at 10 °C in a Beckman MLS-50 rotor. 20 l of each fraction
sample (22 fractions total) was subjected to RT-qPCR. The 135
Sparticlewasmadeinvitrofromnative160Svirionsbyheating
for 3 min in a low salt buffer (4 mM CaCl2,2 0m M HEPES, pH
7.4).
RESULTS
Generation of EV71(FY)-Luc Pseudovirus for Single Round
Infection—To dissect the molecular interaction mechanism of
EV71anditsreceptors,wefirstestablishedasingleroundpseu-
dotype EV71 reporter virus system that allowed us to study
EV71 infection solely at the entry level. The EV71 replicon and
plasmid expressing EV71 capsid proteins were constructed
from an EV71 virus (FY, C4 strain) isolated in Fuyang, China.
The subgenomic replicon plasmid (EV71 FY Subgenomic Rep-
licon)containsUTRs,fireflyluciferase(Luc)reportergene,and
all nonstructural protein regions with a T7 promoter sequence
inserted at the 5-end. The capsid-expressing plasmid (EGFP
EV71 FY Capsid) contains all the capsid genes (VP1–VP4) and
an EGFP reporter gene that are under the control of a CMV
promoter (Fig. 1A). The single round entry virus was produced
by sequential transfections of the capsid-expressing plasmid
andEV71FYsubgenomeRNAthatwastranscribedfromEV71
FY Subgenomic Replicon in vitro (see “Materials and Meth-
ods”). The produced virus is designated as EV71(FY)-Luc.
Unlike the replication-competent EV71(FY)-EGFP virus,
which contains the full-length RNA genome of EV71 with an
EGFPreporterinsertedbetweenthe5-UTRandVP4(Fig.1A),
EV71(FY)-Luc pseudotype viruses can only enter target cells
once because they lack structural genes and their capsid pro-
teins were provided in producing cells in trans. In an ultracen-
trifugation analysis, EV71(FY)-Luc pseudotype viruses mi-
grated the same as the wild type virus in a discontinuous
15–30% sucrose gradient (Fig. 1B). Moreover, convalescent
sera of patients recovered from EV71 infection neutralized the
infection of EV71(FY)-Luc pseudoviruses in a dose-dependent
manner (Fig. 1C). These results demonstrated that the single
round EV71(FY)-Luc pseudotype virus system can be used as a
surrogate for wild type virus to study viral entry. This system
provides a sensitive and quantitative approach to investigate
the detailed molecular interaction between EV71 and receptor
attheentrylevelonlyandisdevoidofanyambiguitythatmight
be caused by postentry events.
SCARB2s from Several Animal Species Support Infection by
EV71 with Different Efficiencies—SCARB2, a type III glycopro-
tein with both N and C termini within the cytoplasm, is endog-
enously expressed on a wide range of tissues and cells in differ-
ent species. It is located primarily on the membranes of
lysosomes and late endosomes, and its cell surface expression
level varies significantly among different cells (28). We estab-
lished stable SCARB2 knockdown RD cell lines (RD/SCARB2
kd) by using a lentivirus-based system that carries hSCARB2-
specific shRNA. The hSCARB2 mRNA expression level was
reduced by 90% in the RD/SCARB2 kd cells as compared with
RD cells that were transduced with an irrelevant shRNA (RD/
shNC cells) (Fig. 2A, left panel). The binding activity of
EV71(FY)-Luc pseudotype virus to RD/SCARB2 kd cells was
greatly reduced (Fig. 2A, right panel). To compare the suscep-
tibilityofRD,RD/SCARB2kd,andRD/shNCcellstoEV71viral
infection, we infected these cell lines with a fully replication-
competent EV71(FY)-EGFP virus that was produced by trans-
fection of RD cells with EV71(FY)-EGFP RNA transcribed in
vitro(see“MaterialsandMethods”).Asshowninsupplemental
Fig. 1A, EV71(FY)-EGFP efficiently infected RD and RD/shNC
cells but not RD/SCARB2 kd cells. Cytopathic effects were also
observed in RD and RD/shNC cells but not in RD/SCARB2 kd
cells(supplementalFig.1B).Toexaminewhetherexpressionof
human SCARB2 can rescue EV71 infection in RD/SCARB2 kd
cells, we transfected the cells with an expression construct that
encodes hSCARB2 but with a silent nucleotide mutation
(hSCARB2smut) that makes the shRNA against SCARB2 inef-
fective. As expected, transient transfection of RD/SCARB2 kd
cells with the hSCARB2smut, but not control vector (mock),
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 resultedinstrongrestorationofEV71infection(Fig.2B,farleft
panel). These results confirmed that hSCARB2 is sufficient to
permit EV71 infection in RD/SCARB2 kd cells.
It has been shown that cynomolgus monkeys and to a
lesser extent suckling mice and nonobese diabetic/severe
combined immunodeficient mice can be infected with EV71
bearing adaptive mutations (29). Whether EV71 can infect
other animals is currently unknown. We cloned and
sequenced SCARB2 genes from horseshoe bat, mouse, and
hamster and aligned their predicted amino acid sequences
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 withhSCARB2(supplementalFig.2).Thealignmentshowed
that human SCARB2 and SCARB2s from the other three
species share 86% identity and more than 94% similarity.
The functions of these SCARB2s in mediating EV71 infec-
tion were tested by receptor complementarity experiments.
SCARB2s were transiently transfected into RD/SCARB2 kd
cells, the cells were infected with EV71(FY)-EGFP (Fig. 2B)
orinseparateexperimentstransfectedintoBHK21cells,and
then infected with EV71(FY)-Luc (Fig. 2C). EV71(FY)-EGFP
infected mouse or hamster SCARB2-expressing cells less
efficiently compared with human SCARB2-expressing cells
(RD/SCARB2 kd cells transfected with SCARB2smut as
described above) (Fig. 2B). This result is consistent with a
recently published study showing that mouse SCARB2 does
not support robust EV71 infection (23). Interestingly, cells
expressing horseshoe bat SCARB2 supported more efficient
EV71(FY)-EGFP viral infection (Fig. 2B).
To confirm that the species difference of SCARB2 in sup-
portingEV71infectionwassolelyattheentrylevel,wealsoused
the single round EV71(FY)-Luc system that contains firefly
luciferase as a reporter to quantify viral infectivity on receptor-
complemented cells. SCARB2s from human, mouse, hamster,
and horseshoe bat were transfected into BHK21 cells, surface
expression of these SCARB2s was determined, and the cells
were infected with EV71(FY)-Luc reporter virus. Luciferase
activitywasdetermined24hpostinfection.Consistentwiththe
infection of EV71(FY)-GFP that is replication-competent but
with a much clearer difference, infection of single round
EV71(FY)-Luc on various SCARB2s from different species is
distinct. EV71(FY)-Luc infected human and horseshoe bat
SCARB2-expressing cells efficiently; the infectivity on bat
SCARB2 cells is 80% of that on hSCARB2 cells, and appar-
ently there are no postentry restrictions of BHK21 cells for
EV71 infection. However, mouse and hamster SCARB2-ex-
pressing cells were infected poorly (up to 32% of the infectivity
in hSCARB2 cells; Fig. 2C). Although the surface expression
level of SCARB2 from mouse and hamster was actually slightly
higher than that from human (Fig. 2D), they only support lim-
ited EV71(FY)-Luc infection (Fig. 2C).
Identifying Critical Residues of SCARB2 for EV71 Infection—
The amino acid sequence alignment of SCARB2 from human,
horseshoe bat, mouse, and hamster revealed four highly vari-
ableregions(HVRs)inthereceptor:HVR1(residues144–151),
HVR2 (residues 188–198), HVR3 (residues 278–288), and
HVR4(residues354–365)(supplementalFig.2).Toidentifythe
critical binding region of SCARB2 for mediating virus binding,
twomouse/humanSCARB2chimerasandfourHVR1-,HVR2-,
HVR3-, and HVR4-swapped mutants were constructed. The
twochimerasweredesignatedasHM(N-terminal300residues
from human and the remaining 178 residues from mouse) and
MH (N-terminal 300 residues from mouse and the rest from
human) (supplemental Fig. 3A), whereas each of the HVR-
swapped hSCARB2 mutants has one of the four HVR regions
replacedwiththatofmSCARB2(Fig.3A).Thereceptoractivity
of these variants was examined by transient transfection into
RD/SCARB2 kd and/or BHK21 cells and followed by
EV71(FY)-GFP or EV71(FY)-Luc infection. All the SCARB2
variantswereexpressedatcomparablelevelsonthecellsurface
(Fig. 3, D and F, upper panels, and supplemental Fig. 3C, right
panel). Infection of HM SCARB2-expressing cells was as effi-
cient as that of hSCARB2 cells. In contrast, the reciprocal
SCARB2 chimera MH-expressing cells showed a significant
reduction in infection (supplemental Fig. 3, B and C), which is
consistent with a recent report that the N terminus of SCARB2
is important for EV71 binding and infection (23). Mutant
SCARB2 HVR1-LOF (human HVR1 residues 144–151
replaced with mouse HVR1, loss-of-function (LOF) mutant)-
expressingcellsshowedreducedsusceptibilitytoviralinfection
(30% reduction as compared with wild type hSCARB2),
whereasHVR2-LOF,HVR3-LOF,andHVR4-LOFmutantsdid
not significantly affect viral infection as shown by EV71(FY)-
GFP(Fig.3C)andEV71(FY)-Lucviralinfectionassays(Fig.3D).
Sequence comparison of HVR1 of SCARB2 across species
showed that only one common amino acid (Gln-148) of the
eight residues is shared by all four species (Fig. 3B). Based on
HVR1 sequence alignment, SCARB2s can be divided into two
groups: group 1 containing mouse and hamster and group 2
containinghumanandhorseshoebat.Forbothgroups,thetwo
members within each group share five identical residues.
Between groups, e.g. human and mouse SCARB2, seven of the
eight amino acids are different (Fig. 3B). To confirm that the
residues in HVR1 are responsible for the reduced susceptibility
of mouse SCARB2-expressing cells to EV71 infection, we
altered three of the seven different residues to their human
counterpart in the HVR1 of mSCARB2, e.g. from VDLAQLTL
to VDWAQLHF (WHF_GOF (gain-of-function mutant)), or
theotherfourdifferentresiduestotheirhumancounterparton
the HVR1 of mSCARB2 from VDLAQLTL to IELSQVTL (IES-
V_GOFmutant)andfoundthatbothmutantscouldnotrestore
infectivity. However, remarkably, when all seven different resi-
FIGURE 1. Single round EV71 infection system. A, schematic map of the EV71 viral RNA genome, replication-competent EV71(FY)-EGFP viral genome, and
EV71 replicon and capsid expresser for the single round EV71 infection system, EV71(FY)-Luc. EV71(FY)-EGFP is a replication-competent virus with the EGFP
reportergeneinsertedbetweenthe5-UTRandVP4.AnEV712Aproteaserecognitionsite(-AITTL-)wasinsertedbetweenEGFPandVP4.Forthesingleround
EV71 infection system (EV71(FY)-Luc), the EV71 capsid expresser was used to express all the structural capsid genes in trans, an EGFP gene was inserted
upstreamoftheEV71(FY)capsidgene,andallotherEV71viralgenesweredeleted.TheEGFPwasseparatedfromthestructuralgenesbya2Aself-cleavagesite.
EV71repliconwasproducedbyreplacingthecapsidcodingregionwithafireflyluciferasereportergeneinthefull-lengthEV71(FY)genome,andaT7promoter
wasplacedatthe5-endfortranscriptioninvitro.B,characterizationofEV71pseudotypevirusbyultracentrifugation.BothwildtypeEV71(FY)andpseudotype
virus EV71(FY)-Luc were applied to sucrose gradient ultracentrifugation, and the copy number of viral genomic RNA in each fraction was subsequently
determinedbyquantitativeRT-PCR.EV71(FY)viruswasquantifiedwithprimerslocatedinVP1.Specificprimersforfireflyluciferasereportergenewereusedfor
quantifyingpseudotypeEV71(FY)-Lucvirus.Thedatashownarerepresentativeofthreeindependentexperiments.ErrorbarsrepresentS.D.betweenduplicate
samples analyzed in the experiment. C, inhibition of EV71(FY)-Luc pseudotype viral infection of RD cells. EV71 pseudotype virus was incubated with patient
anti-EV71 serum samples at 4 °C for 1 h prior to infection of RD cells in a 96-well plate in a total volume of 100 l in quadruplicate. Luciferase activity was
measured24hpostinfection.Non-linearregressionanalysisoftheneutralizationcurveofanti-EV71serumwasconductedusingGraphPadPrism.N3,N12,and
N25 are convalescent sera from different patients that showed low, medium, and high neutralization activity, respectively, against EV71 infection in a classic
plaque reduction assay. IRES, internal ribosome entry site.
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 dues between mouse and human SCARB2 were switched from
mousetothehumancounterpart(IEWSQVHF(HVR1_GOF)),
highlyefficientEV71infectionwasobservedandreached85%
oftheinfectivityofhSCARB2(Fig.3,EandF),demonstratinga
critical role of these seven residues in HVR1 in SCARB2 inter-
action with the virus.
EV71 Enters Cells via Canyon around Gln-172 Residue on
VP1—Picornavirus VP1 protein is arrayed around the 5-fold
axisonthevirionsurface,itishighlyexposed,anditisthemost
prominent structural protein. VP1 plays an important role in
mediatingreceptorbindingforviralentry,anditssequencehas
beenusedforpicornavirusclassification(30).Ithasbeenshown
FIGURE2.SCARB2fromdiversespeciessupportsEV71infectionwithvariousefficiencies.A,SCARB2knockdownRD(RD/SCARB2kd)cellline.Leftpanel,
the SCARB2 mRNA levels in RD cells, stable RD/SCARB2 kd cells, and control RD cells treated with an unrelated shRNA were determined by real time PCR. The
SCARB2 mRNA levels for each cell line were normalized using GAPDH as an internal control. Right panel, relative binding efficiency of EV71 pseudotype virus
EV71(FY)-Luc to RD and RD/SCARB2 kd cells. The data are shown as averages and S.D. from triplicates analyzed in one experiment, which is representativeo f
three independent experiments. B, SCARB2s from human and horseshoe bat supported more efficient EV71(FY)-EGFP infection than those from mouse and
hamster. Human SCARB2 (SCARB2smut that carries nonsense nucleotide mutations to mismatch shRNA target sequence) and SCARB2s of horseshoe bat,
mouse,andhamster,respectively,weretransientlytransfectedintoastableSCARB2kdcellline.24hpost-transfection,cellswereinfectedwithEV71(FY)-EGFP
viruses, and infected cells were photographed 24 h postinfection. C, single round EV71(FY)-Luc infection of cells complemented with SCARB2 from human,
mouse,hamster,andhorseshoebat.BHK21cellsweretransfectedwithplasmidsencodingSCARB2(fusedwithaC9tagattheCterminus)fromdifferentspecies
as indicated, and the cells were then infected with EV71(FY)-Luc reporter virus. Luciferase activity was determined 24 h postinfection, and the percentage of
infectivitywascalculatedandnormalizedtotheinfectivityofhumanSCARB2-transfectedcellsconsideredas100%.InfectionofEV71(FY)-Lucinuntransfected
BHK21 cells was used as a control. The data reflect the means with S.D. bars from quadruplicate data points within one experiment. Similar results were
obtained from three independent experiments. D, cell surface expression of SCARB2s. BHK21 cells from the same transfections as in C were harvested 24 h
post-transfection,cellsurfacemoleculeswerebiotinylated,andcellswerelysed.ThebiotinylatedSCARB2swerethenpulleddownwithaC9-specificantibody,
1D4, from the cell lysate and subsequently detected with HRP-streptavidin by Western blot. Untransfected BHK21 cells were used as a control.
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 FIGURE 3. Identification of critical residues on SCARB2 for EV71 infection. A, schematic diagram of chimeric SCARB2 proteins. Swap mutants of human
SCARB2withresiduesfrommouseSCARB2atthehighlyvariableregions(HVR1,HVR2,HVR3,andHVR4,respectively)weregeneratedbyreplacingthehuman
SCARB2sequence(black)withthemurinecounterpart(white).Thepositionsoftheaminoacidsexchangedareindicated.MouseSCARB2withthree(WHF),four
(IESV), or seven (HVR1) GOF mutant residues was constructed by replacing the corresponding murine residues with their human counterparts on a mouse
SCARB2 expression plasmid. All SCARB2s contain a C9 tag at the C terminus. TM, transmembrane domain. B, amino acid alignment of the HVR1 region of
SCARB2sfromfourdifferentspeciesandGOFmutantsofmouseSCARB2.GOFmutantsarethethree-(WHF),four-(IESV)orseven-residue(HVR1)mutationsin
the HVR1 region. Residues changed from mouse to human are indicated with underlines. C and D, swapping the HVR1 of human SCARB2 with the mouse
counterpart interferes with EV71 infection. RD SCARB2/kd cells transfected with plasmids encoding human SCARB2, mouse SCARB2, or human SCARB2
HVR1–4LOFmutantswereinfectedwithreplication-competentEV71(FY)-GFP.Infectedcellswerephotographed18hpostinfection(C).InfectionsofEV71(FY)-
Luc pseudotype virus were determined on BHK21 cells transfected with various SCARB2s. Firefly luciferase reporter activity was measured 24 h postinfection
(D, lower panel), and the surface expression of these SCARB2 variants was also examined (D, upper panel). All SCARB2s contained a C9 tag at the C terminus.
UntransfectedBHK21cellswereusedasacontrolinD.EandF,introductionofsevenresiduesofhumanSCARB2intomouseSCARB2convertsmouseSCARB2
to an efficient EV71 receptor for viral infection. EV71(FY)-GFP infection (E) was recorded as in C. For EV71(FY)-Luc infection (F), surface expression of SCARB2
mutants was determined for BHK21 cells transfected with SCARB2s (F, upper panel). EV71(FY)-Luc infection in these cells was measured 24 h postinfection (F,
lowerpanel).UntransfectedBHK21cellswereusedasacontrolinF,andtheinfectivityofEV71(FY)-LucinBHK21cellstransfectedwithhSCARB2wassetas100%.
Allthedatashownrepresentthreeormoreexperiments.CellsurfaceexpressionofSCARB2swasdeterminedsimilarlytothatinFig.2D.ForbothDandF,the
data are representative of three independent experiments. Error bars represent S.D. from quadruplicate samples analyzed within the experiment.
CapsidandReceptorDeterminantsforEnterovirus71Entry
FEBRUARY24,2012•VOLUME287•NUMBER9 JOURNALOFBIOLOGICALCHEMISTRY 6413
 
a
t
 
H
A
R
V
A
R
D
 
U
N
I
V
E
R
S
I
T
Y
,
 
o
n
 
F
e
b
r
u
a
r
y
 
2
8
,
 
2
0
1
2
w
w
w
.
j
b
c
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 that VP1 of EV71 is involved in binding SCARB2 and is the
capsid protein responsible for EV71 viral entry; however,
molecular details of the interaction between VP1 and SCARB2
are lacking. We aligned VP1 protein sequences of several EV71
strains including currently circulating strains and found muta-
tion hot spots in VP1 (supplemental Fig. 4). We hypothesized
that these mutation hot spots might be a result of evolutionary
pressures, such as mutants that can escape host neutralizing
antibody and/or mutations for host adaptation with higher
receptor binding efficiency. We therefore mutated these resi-
duesonVP1oftheEV71(FY)straintoalanineandincorporated
them into EV71(FY)-Luc pseudotype viruses. Using the VP1
mutant viruses, we examined the efficiency of their binding to
SCARB2 on RD cells and their functions for mediating
EV71(FY)-Luc infections. A set of mutations covering 20 sol-
vent-exposed residues on VP1 was initially examined by quan-
tifyingthepseudovirusparticlesboundonRDcellsusingquan-
titative RT-PCR targeting viral genomic RNA. Among all the
VP1 mutants tested, EV71(FY)-Luc bearing the Q172A VP1
mutation showed the most dramatic loss in both binding and
infectionactivityonRDcells(Fig.4,AandB;notallmutantsare
shown).
We subsequently mutated all the surface residues in the
vicinityofGln-172basedonthestructuralmodelofEV71VP1,
which shares high sequence identity with the poliovirus VP1
templatestructure(ProteinDataBankcode3EPC).Atotalof15
additional VP1 capsid mutations were made and examined for
their activity for both receptor binding and viral infection. In
addition to Q172A, EV71 pseudotypes bearing VP1 mutations
atresiduesGln-152,Arg-166,Trp-171,Thr-173,Thr-175,Asn-
176, Ser-178, Phe-180, and Arg-236 showed greatly decreased
viralbindingandinfectivityinRDcells(Fig.4C).Toensurethat
the mutations did not interfere with virus assembly, we quan-
tified the genome copy numbers of viral RNA of these VP1
mutantpseudotypevirusesbyquantitativeRT-PCR.Theresult
showedthatvirusassemblyofmostmutantswithreducedviral
binding and infectivity was not impaired significantly as com-
pared with that of other mutants. Of all residue tested, only
N176A showed reduced binding and infection with lower
assembly efficiency (Fig. 4C, upper panel). A Western blot was
also performed to detect the level of VP1 on purified Q172A
mutant pseudotype viruses. As shown in Fig. 4D, the level of
VP1 detected by anti-EV71 serum on Q172A VP1 mutant
viruses was similar to that on the pseudotype viruses bearing
wild type VP1 or the three other VP1 mutants, P161A, K162A,
and L169A, that are located in the vicinity of Gln-172 with
either a minor or no effect on EV71 pseudovirus binding or
infection in RD cells. To demonstrate the direct interaction
between VP1 and SCARB2, we examined the binding of wild
typeandselectedmutantsincludingtheQ172Amutantviruses
with purified, soluble SCARB2 by a pulldown experiment (Fig.
4E). As expected, binding of SCARB2 to mutant viruses was
reduced(P161A/K162A)orabolished(Q172A)consistentwith
the reduced or loss of binding and infectivity of those mutants
inRDcells.Collectively,theseresultsdemonstratethataregion
aroundresidueGln-172onVP1iscriticallyimportantforEV71
infection mediated by SCARB2.
Next we constructed a three-dimensional structural model
of EV71 virion by replacing the VP1 of poliovirus with that of
EV71 in the cryo-EM structure of poliovirus (31). As shown in
Fig.4F,leftandmiddlepanels,a“canyon”regionsimilartothat
on poliovirus was observed on the EV71 virion surface. Inter-
estingly, Gln-172 and other adjacent residues on VP1 that are
critical for receptor binding and viral infectivity as revealed by
our mutagenesis studies were mapped to the canyon region on
the model of EV71 virion. These residues line the wall of the
canyon and are mainly on the EF loop region (loop connecting
-strands E and F) (Fig. 4F, right panel, and supplemental Fig.
2). Taken together, it is likely that EV71 binds to SCARB2 via
the canyon region on VP1 that is probably composed of resi-
dues Gln-152, Arg-166, Trp-171, Gln-172, Thr-173, Thr-175,
and Ser-178.
SCARB2 Is Uncoating Receptor of EV71—For a productive
infection, viral RNA genome must be released into the cyto-
plasm of the host cells. For some enteroviruses, receptor
engagement is the initial trigger of the viral uncoating process
that involves capsid alterations by conformational changes. As
a result, different virus particles are formed during viral entry:
mature enterovirus particles sediment at 160 S, whereas the
other two forms of viral particles sediment at about 135 and 80
S(32).The80Sparticlesrepresentthefinalproductoftheentry
process(theyareemptyparticlesthathaveshedgenomicRNA),
whereas the 135 S particles still retain the full complement of
genomic RNA but lack some or all of their content of VP4 and
haveexternalizedmostoftheN-terminalextensionofVP1that
is normally inside the virions. Conversion from native mature
160 S particles to the 135 S particles can occur intracellularly
following cellular receptor engagement; it can also be induced
in some cases with soluble receptors in solution or by simply
heatingthe160Svirusparticlesto50 °Cforashorttimeinalow
salt buffer (33). It is unknown whether SCARB2 serves as an
uncoating receptor for EV71 entry. In those enteroviruses for
which receptor binding triggers virus uncoating (conversion
from160Sto135Sparticles),thereceptorsusuallydockwithin
the canyon on the virus surface. Our data have shown that
SCARB2 binds to the canyon area on VP1 of EV71; therefore,
we surmised that SCARB2 engagement may trigger virus
uncoating, and thus, SCARB2 might serve as an uncoating
receptor for EV71 infection. To examine this, we expressed
soluble SCARB2 as mouse IgG2a Fc (mFc) fusion proteins by
transient transfection of 293T cells with their encoding plas-
mids (Fig. 5A, left panel). As expected, the hSCARB2-mFc
fusion proteins pulled down EV71 virus efficiently as did the
HVR1-GOF mutant (HVR1 of mouse SCARB2 replaced with
human HVR1), but not the mouse SCARB2 did not (Fig. 5A,
right panel). We then prepared EV71 135 S particle by heating
purified wild type EV71 virions and used it as a reference for
testing whether soluble receptor could induce virus particle
conversion from 160 S to 135 S. By ultracentrifugation in a
15–30% discontinuous sucrose gradient, the heat-treated viral
particles shifted from the major peak fraction 15–16 (160 S) to
fraction 10 (135 S) (Fig. 5B, upper panel). To test whether sol-
uble receptor could induce virus uncoating, 5 g of purified
hSCARB2-mFc was mixed with EV71 particles that were puri-
fied by CsCl ultracentrifugation and incubated overnight, then
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 thetemperaturewasshiftedto37 °C,andthemixturewasincu-
bated at 37 ºC for 100 min. The mixture of virus and receptor
was then subjected to ultracentrifugation at 40,000 rpm for 70
minat10 °C.AsshowninFig.5B(middlepanel),solublerecep-
tor hSCARB2-mFc was able to uncoat the viruses: 15% of
intact virions (in fraction 15–16; 160 S) shifted to fractions
8–12, a position identical to that of the 135 S particle induced
by heating the virus. Moreover, when the mixture was incu-
bated at 37 °C under low pH (5.6) treatment, the shift from
160Sto135Sparticleswasmuchmoredistinct(Fig.5C,middle
panel) compared with that under neutral pH (Fig. 5B, middle
panel).WealsotestedtwoothermFcfusionproteins:theextra-
cellular domain of human PSGL-1 and the seven HVR1 resi-
dues of hSCARB2; both were fused at the N terminus of the
mouse IgG2a Fc (supplemental Fig. 5A, left panel). Although
soluble PSGL1-mFc could bind EV71 efficiently (supplemental
Fig. 5A, right panel), neither PSGL1-mFc (Fig. 5B, bottom
panel) nor HVR1-mFc (data not shown) could effectively
uncoatEV71virions.Ofnote,treatmentwithlowpHalone(Fig.
5C,upperpanel)orPSGL-1pluslowpH(Fig.5C,bottompanel)
did not alter the distribution of the virions upon ultracentrifu-
gation. These results support that SCARB2, but not PSGL-1, is
an uncoating receptor of EV71 and that low pH can facilitate
conformationaltransition(s)ofEV71viralparticles.Consistent
with this, it was recently reported that low endosomal pH is
required for EV71 infection (17), and we also observed that
endosome acidification inhibitors such as bafilomycin A1 and
ammonium chloride efficiently inhibited EV71(FY)-GFP and
EV71(FY)-Luc entry (supplemental Fig. 5B).
DISCUSSION
In addition to SCARB2, several other cell surface molecules
includinghumanPSGL-1(18,19),sialicacid-linkedglycan(34),
dendritic cell-specific intercellular adhesion molecule-3-grab-
bing non-integrin (DC-SIGN; CD209) (35), and annexin II (36)
havealsobeendemonstratedtofacilitateEV71entry.However,
SCARB2 is likely an indispensable receptor for EV71 infection.
Viral infection in RD cells is greatly reduced when the interac-
tion between EV71 and SCARB2 is blocked by antibodies (18,
19) or in RD cells in which SCARB2 expression is knocked
down. SCARB2 is ubiquitously expressed on a wide range of
tissues and cells in different species; however, the expression
level, particularly on the cell surface, could vary significantly
among different cells. It is located primarily on the membranes
of lysosomes and late endosomes and has been implicated in
participating in maintaining endosomal transport and lyso-
somal biogenesis (37, 38). Eckhardt et al. (39) showed that only
10–20%ofSCARB2wasexpressedonthesurfaceoftransfected
Chinese hamster ovary cells; the majority of the rest was
expressed on intracellular membranes. We made RD/SCARB2
kdcelllineinwhichthemRNASCARB2expressionwassignif-
icantly knocked down (Fig. 2A) and its function in supporting
viral entry is completely knocked out (supplemental Fig. 1).
Intriguingly, the viral binding activity of the RD/SCARB2 kd
cellsremainedupto50%ascomparedwithRDcells.Asthere
is no detectable PSGL-1 mRNA in RD cells (data not shown),
the viral particle may bind to cells via other attachment fac-
tor(s)onRD/SCARB2kdcells.However,theattachmentmedi-
ated by other factors is unlikely to be productive in terms of
infection.
In this study, we cloned horseshoe bat (Rhinolophidae fam-
ily) and hamster SCARB2 genes that have not been reported
previously. RD/SCARB2 kd or nonsusceptible BHK21 cells
transfected with SCARB2s from four different species (horse-
shoe bat, hamster, mouse, and human) showed various suscep-
tibilities to EV71 infection. Viral infection assays were carried
out with both replication-competent EV71 recombinant EGFP
reporter virus (EV71(FY)-EGFP) and pseudotype EV71 single
round viruses (EV71(FY)-Luc), and similar results were
obtained for both viral infection systems. This confirmed that
the infectivity difference among these cells is solely attributed
toaspeciesdifferenceoftheSCARB2receptorattheviralentry
level. The bat SCARB2-expressing cells supported viral infec-
tion efficiently (equal to 80% of human SCARB2 cells),
whereas BHK21 cells expressing hamster or mouse SCARB2
poorly supported EV71 infection (30% of human SCARB2 by
luciferase assay). Although humans are the only known natural
hosts of enteroviruses including EV71, it is intriguing that bat
SCARB2-expressing cells can be infected by EV71 efficiently.
Bat is a unique and enigmatic group of mammals that account
for20%ofextantmammalianspecies(40).Alargenumberof
viruses have been isolated from or detected in bats. Highly
pathogenic viral diseases due to transmission of viruses from
bats have been demonstrated for rabies virus, lyssaviruses, and
Nipah and Hendra viruses and can be inferred for severe acute
respiratory syndrome coronavirus-like virus. Therefore, bats
havebeenincreasinglyrecognizedasreservoirhostsforviruses
FIGURE4.EV71enterscellsviacanyonaroundGln-172residueonVP1.A,effectofmutationsonsurface-exposedVP1residuesforEV71infectionofRDcells.
B, effect of VP1 mutants on viral binding activity in RD cells. C, mutagenesis analysis of VP1 around Gln-172 revealed a cluster of residues involved in the
interactions between VP1 and SCARB2 as shown by reduction in viral binding and RD cell infectivity. Upper panel, RNA genome copies of each mutant virion
wereexaminedwithqRT-PCR.Middlepanel,mutantvirusbindingtoRDcells.TheRDcell-boundEV71(FY)-LucvirionswerequantifiedbyRT-qPCR,andbinding
ofmutantviruswasnormalizedtothepseudotypevirusbearingwildtypeVP1.Bottompanel,mutantviralinfectivitymeasurement.EV71(FY)-Lucpseudotype
mutantviruseswereusedtoinfectRDcellsinquadruplicate,andviralinfectivitywasmeasured24hpostinfectionbyluciferasereporter.Infectivityofmutant
virus was normalized to the wild type EV71(FY)-Luc viruses. D, Western blot analysis of VP1 proteins on mutant EV71 pseudovirions. The same amounts of
pseudovirions(normalizedbyviralRNAgenomecopiesquantifiedbyqRT-PCR)bearingmutantVP1asindicatedwereexaminedforVP1proteinlevelsonthe
virions by Western blot. Pseudovirions were concentrated by ultracentrifugation, and VP1 proteins were detected by mouse anti-EV71 polyclonal serum.
E, SCARB2-mFc pulldown assay on EV71 pseudovirions carrying mutant VP1. 1 g of purified SCARB2-mFc fusion protein was incubated with 5  10
8
pseudovirions bearing wild type or mutant VP1 at 4 °C for 4 h in the presence of protein A beads. After extensive washing with PBS three times, the bound
virions were quantified by RT-qPCR. The data shown in A–E are representative of 2–3 independent experiments for each panel. Error bars represent S.D. from
triplicate samples analyzed within one experiment. F, the potential binding interfaces between the canyon on EV71 VP1 and SCARB2 were mapped on the
three-dimensional architecture of EV71 virus capsid. The capsid architecture shown was built by replacing the VP1 on the cryo-EM structure of poliovirus
(ProteinDataBankcode2PLV)withourmodeledVP1structure.TheEV71VP1residueswhosealterationsubstantiallydecreasedSCARB2bindingarecolored
in red (Gln-152, Arg-166, Trp-171, Thr-173, Gln-172, Thr-175, Asn-176, Ser-178, Phe-180, and Arg-236, respectively).
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 FIGURE 5. SCARB2 is an uncoating receptor of EV71. A, pulldown assay of EV71 with soluble SCARB2-mFc variants. Left panel, SDS-PAGE of purified
SCARB2-mFc fusion proteins with the extracellular region of human or mouse SCARB2 or HVR1-GOF-mFc. Right panel,1g of SCARB2-mFc proteins
shownontheleftwasincubatedwith1lofpurifiedEV71(FY)wildtypevirus(5  10
8 virions)at4 °Cfor4hinthepresenceofproteinAbeads.After
extensivewashingwithPBSthreetimes,theboundvirionswerequantifiedbyRT-qPCR.1gofunrelatedmFcfusionprotein(coronavirusHKU1S1-mFc)
was used as a control. All data points show means and S.D. (error bars) for duplicate samples from a representative experiment (n  3). B and C, virion
flotation assay with sucrose density gradient ultracentrifugation. Purified virus (5  10
9) was incubated with 5 g of hSCARB2-mFc or hPSGL1-mFc
followed by incubation at 37 °C for 100 min at neutral pH (B)o rp H5 . 6( C) and then loaded onto a 15–30% discontinuous sucrose gradient for
ultracentrifugation at 40,000 rpm for 70 min at 10 °C in a Beckman MLS-50 rotor. 20 l of each fraction of a total 21 fractions was subjected to RT-qPCR
to quantify virus in each fraction. The 135 S reference particle was made in vitro from native 160 S virions by heating for 3 min in a low salt buffer (4 mM
CaCl2,2 0m M HEPES, pH 7.4).
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 that can cross species barriers to infect humans and other
domestic and wild mammals (41). Very recently, three novel
picornaviruses were discovered from diverse bat species (42).
The question remains whether horseshoe bats could be
infectedbyEV71and/orserveasahostorreservoirforEV71in
nature. It would be interesting to investigate whether EV71 or
EV71-like viral RNA and/or anti-EV71 antibodies can be
detected in horseshoe bats or other species of bats.
It is worth noting that the EV71(FY)-EGFP was able to rep-
licate and spread viruses in RD cells efficiently. Cytopathic
effects were observed in RD cells but not in RD/SCARB2 kd
cells. This is different from the EV71-GFP reporter virus gen-
erated from an infectious clone of EV71 strain SK-EV006 that
had a defect in spreading viruses in RD cells for unknown rea-
sons and thus was used as a surrogate for single round virus in
infection assays in a recent report (23). Here we produced gen-
uine single round EV71 viruses by sequential transfection of an
EV71structuralgeneexpresserandanEV71repliconbearinga
luciferase reporter in producing cells. The resultant pseudovi-
ruses can only enter the target cell once because they are not
able to produce any infectious progenies for a second infection
in target cells due to a lack of structure genes on the replicon.
Upon ultracentrifugation analysis, the pseudotype virus exhib-
itedasedimentationpatternsimilartothatofwidetypevirus.It
could also be neutralized by patient sera in a dose-dependent
manner.ThesingleroundEV71systemprovidesasensitiveand
quantitative approach to examine EV71 infection at the entry
level and is devoid of any ambiguity that might be caused by
postentry events. Moreover, this system is safer to work with
than replication-competent viruses and is particularly useful
for testing antiviral reagents including neutralizing antibodies
orsmallmoleculedrugs,serologicalscreeningofviralinfection,
and evaluations of vaccine sera.
To identify critical binding residues in SCARB2 responsible
for viral binding, amino acid sequences of SCARB2 from four
species (two non-efficient receptors (mouse and hamster) and
two efficient receptors (bat and human)) were analyzed.
Despite that SCARB2s from those four species share high
sequencehomology,fourregionsshowingahighdegreeofvari-
ance were found among the four species. Cells expressing the
HVR1 (residues 144–151) human SCARB2 mutant (human
HVR1 replaced with mouse HVR1) had reduced susceptibility
to viral infection as compared with wild type hSCARB2,
whereas HVR2-, HVR3-, and HVR4-swapped mutants did not
affect viral infection. This result indicates that HVR1 of human
SCARB2 is a region critical for viral infection. This was further
confirmed by three other mouse SCARB2 gain-of-function
mutants (WHF-, IESV-, and HVR1-GOF). The WHF and IESV
mutants that had three and four of the seven residues, respec-
tively,intheHVR1mutatedtotheirhumancounterpartdidnot
showasignificantlyincreasedabilitytosupportEV71infection.
However, the HVR1-GOF mutant that had all of the seven dif-
ferent residues between mouse and human SCARB2 mutated
to their human counterpart demonstrated a greatly enhanced
infectivitylevelsimilartothatofhumanSCARB2.Incontrastto
a recent study in which the important amino acids for EV71
infection were localized throughout the entire region of amino
acids 142–204 (23), our study demonstrated it is the seven res-
idues 144–151 that are critical for the viral capsid binding.
Interestingly,thesesevenresiduesareadjacenttoresidues152–
167, which presumably form a coiled coil domain in SCARB2
and have been demonstrated to be necessary for -glucocer-
ebrosidase binding (22).
EV71 as a member of the Enterovirus genus in the picornavi-
rus family is predicted to have an icosahedral capsid architec-
ture similar to that of other enteroviruses consisting of 60 cop-
ies of four capsid proteins, VP1, VP2, VP3, and VP4 (13). The
outersurfaceofthevirionisdominatedbystar-shapedmesasat
the5-foldaxesandbyathree-bladedpropeller-likestructureat
the 3-fold axes. VP1 components are clustered around the
5-fold axes of symmetry, whereas VP2 and VP3 alternate
aroundthe3-foldaxes(1).Thereisadeepcanyonencirclingthe
5-fold axes below VP1 that separates the VP1 clustered star-
shaped mesas from the three-bladed propellers consisting of
VP2 and VP3. This canyon has been shown or structurally pre-
dictedtobethesiteofreceptorengagementformanyvirusesin
the picornavirus family (1). For EV71, it has only been shown
that VP1 is involved in binding to SCARB2 and is the capsid
protein responsible for EV71 viral entry (23). To identify the
determinants on VP1 for receptor binding and determine
whetherEV71adoptsacanyonreceptorengagementmode,we
first aligned amino acid sequences of VP1s from several circu-
lating EV71 strains. Some mutation hot spots, mostly on loop
regions according to secondary structure prediction and
homology modeling, were identified. Because entry of EV71 is
largely mediated by capsid protein VP1, we mutated those res-
idues on VP1 of the EV71(FY) strain to alanine and incorpo-
rated them into EV71(FY)-Luc pseudotype viruses to investi-
gate the efficiency of binding and infection of those mutants.
Among the residues mutated, one is Gln-145 that has been
implicated previously in EV71 adaptation to a murine model
(43, 44). In our study, we did not find a significant effect of the
Q145AmutationoneitherviralbindingorviralinfectioninRD
cells that express human SCARB2. Importantly, residues Gln-
172 and those in its vicinity including Gln-152, Arg-166, Trp-
171, Thr-173, Thr-175, Asn-176, Ser-178, Phe-180, and Arg-
236 were found to be vital for binding to human SCARB2 and
for efficient infection of cells expressing this receptor. To rule
out the potential effect of these mutants on virus assembly, we
quantified the genome copy numbers of viral RNA of the
mutant pseudotype viruses by quantitative RT-PCR and
showed that virus assembly of most of those mutants was not
impaired significantly as compared with that of other mutants.
WealsoconfirmedthattheQ172AmutantVP1proteinlevelon
the pseudotype viruses is similar to that on wild type virus or
other mutants that did not affect receptor binding and viral
infectivity. Our pulldown data on Q172A pseudotype viruses
further support a direct interaction of this residue and
SCARB2. A previous study using synthetic peptides containing
15 overlapping peptides covering the entire VP1 sequence
revealed that a peptide covering residues 163–177 of VP1 is as
efficient as the whole virion in eliciting an EV71-specific IgG
response(45).Anotherreportalsoshowedthataminoacidres-
idues 66–132, a region outside of the binding site identified by
our work, may be involved in the dimerization of VP1 capsid
protein (46). These observations are consistent with our find-
CapsidandReceptorDeterminantsforEnterovirus71Entry
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 ings in that the Gln-172 and residues in its immediate vicinity
are probably exposed. Mutations on these residues are unlikely
to lead to assembly defects of the virus.
It is generally believed that picornavirus particles are primed
and undergo viral “breathing” at physiological temperatures
with transient exposure of portions of VP4 and the N terminus
ofVP1(47,48).Forsomeviruses,likepoliovirus,receptorbind-
ing greatly accelerates the stepwise uncoating process by con-
verting the particles from the native 160 S to the 135 S A parti-
cles (49). Many cellular receptors identified to date for
enterovirus belong to the immunoglobulin superfamily of
receptors(50,51).Theycontaintwotosevenimmunoglobulin-
likedomains,andfrequentlythefirst(membrane-distal)Ig-like
domainprotrudesintothedeepcanyonofthereceptorbinding
site and triggers the disassembling of the particles (52, 53).
Interestingly, SCARB2 is significantly different from existing
enterovirusreceptors.Presumably,boththeNandCterminiof
SCARB2 are embedded in the plasma membrane or more fre-
quently the lysosome membrane. There is no structural infor-
mation available for this or related molecules. It is difficult to
predicttheconfigurationofSCARB2andexactlyhowthismol-
eculemaneuverstoreachthekeybindingsitesofVP1onintact
virions. It is also unknown whether EV71, like several other
picornaviruses, contains a “pocket factor” inside the canyon on
the viral surface (54, 55). Nonetheless, our experiments with
purified human SCARB2 demonstrate that binding of soluble
SCARB2, but not PSGL-1, to EV71 particles could lead to a
major shift of the virions from 160 S to 135 S particles, indicat-
ingthatconformationchangesoccuruponreceptorbindingon
EV71. Remarkably, consistent with the data that infection of
EV71couldbeblockedbyendosomeacidificationinhibitor,the
uncoating efficiency of SCARB2 is significantly higher in an
acidic environment (pH 5.6), indicating that unlike poliovirus
entry,whichispH-independent(49,56),protonationofcertain
residue(s)ofEV71capsidsmightplayanimportantroleinviral
uncoating after receptor binding.
PhylogeneticanalysisindicatesthatcoxsackievirustypeA16
is likely the ancestor of EV71 and that EV71 emerged from
CA16 during the 1940s (57). Both CA16 and EV71 utilize
SCARB2asanentryreceptor(18),butonlyEV71canoccasion-
ally induce neurological symptoms, whereas CA16 rarely does
so. The factors that determine the pathogenic differences of
these two viruses are currently unknown (11, 12). Viral entry is
frequently a determinant of the virulence of a virus (10). Iden-
tification of the viral and receptor determinants of EV71 may
help to elucidate the pathogenic differences of these two
viruses.
Taken together, in this study we localized both receptor and
viral determinants of the virus-receptor interactions. In partic-
ular, residues 144–151 of SCARB2 are critically important for
viral binding and infection. Altering seven residues of
mSCARB2 to the corresponding residues of hSCARB2 con-
verted the mSCARB2 to an efficient receptor for EV71. The
viral determinants for receptor binding was mapped to a can-
yon or “pocket” region on the viral particle surface comprising
residueGln-172andsurroundingresiduesofthecapsidprotein
VP1. We further demonstrated that human SCARB2, but not
PSGL-1, could induce conformational changes of the viral cap-
sid from 160 S to 135 S. Additional conformational changes of
viral capsids in an acidic environment would ultimately lead to
uncoating of the RNA genome in the cytosol.
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FIGURE LEGENDS 
 
SUPPLEMENTAL FIGURE 1.    EV71(FY) -EGFP replicates and spreads in RD cells efficiently.  
A, RD cells and RD cells treated with an unrelated shRNA (RD/shNC) supported robust EV71(FY)-EGFP 
infection; stable SCARB2 knockdown RD cell lines (RD/SCARB2 kd) lost susceptibility to EV71 infection.   
B, RD or RD/SCARB2 kd cells were infected with EV71(FY) virus or EV71(FY) -EGFP stock virus at a M.O.I of 
0.1. Both EV71(FY) and EV71(FY) -EGFP viruses replicated and spread in RD cells efficiently, most cells had 
CPE within 24h after infection, while RD/SCARB2 kd cells infected by EV71(FY) -EGFP virus showed no 
cytopathic effect. The figure shown is photos taken at 72h post infection, CPE is indicated by white arrows. 
 
SUPPLEMENTAL FIGURE 2. Sequence alignment of SCARB2 from different species. Deduced amino acid 
sequences of SCARB2 from human, mouse, hamster and horseshoe bat were aligned. Four regions with high 
sequence variations were designated as HVR1 (residues 144-151), HVR2(residues 188-198), HVR3(residues 
278-288) and HVR4 (residues 354-365), and highlighted with red boxes.  Gene Bank accession number for 
human and mouse SCARB2 is NP_005497 and NP_031670, respectively. ; SCARB2s of hamster and horseshoe 
bat were cloned, sequenced and deposited in Gene Bank with accession numbers of JF965373 and JF965374, 
respectively. 
 
SUPPLEMENTAL FIGURE 3. The N-terminal 300 residues of SCARB2 are involved in EV71 viral 
infection. 
A, Schematic diagram of human-, mouse-, and chimeras SCARB2 proteins.  The HM and MH swap mutants 
were generated by replacing the human SCARB2 sequence (black) with the murine counterpart (white) as 
indicated.   
B, RD/SCARB2 kd cells transfected with plasmids encoding human-, mouse-, HM, or MH SCARB2  were 
infected with EV71(FY)-GFP and the result was recorded 36 hrs post initial infection. 
C, BHK21 cells transfected with plasmids encoding human, mouse, HM, or MH SCARB2 were  infected with 
the single round pseudotype virus EV71(FY)-Luc. Firefly luciferase activity in infected cells was examined 24 hrs 
after infection and the infectivity on different cells was normalized to that of human SCARB2 (left panel). The 
surface expression level of the swap mutants were also determined (right panel). Untransfected BHK21 cell was 
used as a control. 
 
SUPPLEMENTAL FIGURE 4. Sequence alignment of VP1 from different EV71 isolates. 
Deduced amino acid sequences of VP1 from some circulating EV71 virus and the prototype strain of EV71 (BrCr) 
were aligned. The secondary structure of VP1 was shown on bottom of the sequence: E: beta-sheet, H: helix, C: 
coil-coil. The effect of mutations examined was marked as follows: filled star indicates those most effective 
residues for viral binding and infection; open star indicates partial effective residues; triangle indicates no effect. 
Two residues Q145 and Q172 were highlighted in boxes. 
 
SUPPLEMENTAL FIGURE 5. Cellular entry of EV71(FY)-GFP and EV71(FY)-Luc is pH dependent. 
A, PSGL-1 pull-down assay of EV71.  Left panel, SDS-PAGE of purified PSGL-1-mFc (human 
PSGL-1extracellular domain fused with mouse IgG2a Fc (mFc) and HVR1-mFc (seven amino acids IEWSQVHF 
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from HVR1 of human SCARB2 fused with mFc). Right panel, purified proteins (1 μg) shown in left panel were 
incubated with 1μl purified EV71(FY) wild type virus (~5 X 10
8 virions) at 4℃ over night together with protein 
A beads.    After extensive wash with PBS for 5 times, the bound virions were quantified by RT-qPCR.   
B, Cellular entry of EV71(FY)-GFP and EV71(FY)-Luc can be blocked by endosome acidification inhibitor 
bafilomycin A1 and ammonium chloride.    RD cells were pretreated with Bafilomycin A1 or NH4Cl at indicated 
concentration at 37℃for 1h. The cells were infected with EV71(FY)-GFP or EV71(FY)-Luc at 37℃for 1h in 
presence of the chemicals and then were changed to fresh culture medium after washing with PBS once. Cell 
viability was not affected significantly by these inhibitors at tested concentrations. GFP photos were taken at 12 
hrs post infection (upper panel), firefly luciferase activity was examined at 24 hrs post infection and was 
normalized to the infection on untreated cell control (lower panel). 
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